# MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

> **NCT00048061** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 1609 (actual)

## Conditions studied

- Post Menopausal Osteoporosis

## Interventions

- **DRUG:** Ibandronate [Bonviva/Boniva]
- **DRUG:** Ibandronate [Bonviva/Boniva]
- **DRUG:** Ibandronate [Bonviva/Boniva]
- **DRUG:** Ibandronate [Bonviva/Boniva]
- **DIETARY_SUPPLEMENT:** Calcium
- **DIETARY_SUPPLEMENT:** Vitamin D

## Key facts

- **NCT ID:** NCT00048061
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 1609 (ACTUAL)
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00048061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00048061, "MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00048061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*